Concepedia

Mathias Locher

ML

25

Publications

1.4K

Citations

19

H-Index

1985

Active since

Affiliations

University of Florida(Current)

3D-Micromac (Germany)

Bayer (Germany)

University of Tübingen

Roche (Switzerland)

Mathias Locher is an author at University of Florida specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

1985–2015

25

Publications

25

MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors

Klaus Brischwein, Bernd Schlereth, Benjamin Guller et al. · Molecular Immunology · 2005 · 257 citations

, , +6

Strictly Target Cell-dependent Activation of T Cells by Bispecific Single-chain Antibody Constructs of the BiTE Class

Klaus Brischwein, Larissa Parr, Stefan Pflanz et al. · Journal of Immunotherapy · 2007 · 188 citations

High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G

Susanne Preithner, Stefanie Elm, Sandra Lippold et al. · Molecular Immunology · 2005 · 131 citations · Full text

Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases

Michela Silacci, Wibke Lembke, Richard Woods et al. · mAbs · 2015 · 90 citations · Full text

, , +19

Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells

Sandrine d’Argouges, Sandra Wissing, Christian Brandl et al. · Leukemia Research · 2008 · 79 citations · Full text

Rows per page

1–5 of 25